跳至主要内容
临床试验/NCT02079831
NCT02079831已完成不适用

Effects of Varied Macronutrient Composition on Weight Loss in Obese Adolescents

Pennington Biomedical Research Center1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2014年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
32
试验地点
1
主要终点
BMI Z-Score

研究概览

简要总结

The aim of the proposed study is to provide important data on weight loss efficacy in overweight and obese adolescents on an isocaloric higher protein diet vs a lower protein diet utilizing the U.S. Department of Agriculture (USDA) MyPlate nutrition guide. The investigators hypothesize that the higher protein diet will result in greater weight loss due to increased satiety and better dietary adherence.

详细描述

Aim 1 is to test the efficacy of a personalized higher protein weight loss intervention compared to a lower protein intervention which use the USDA MyPlate nutrition guide.

It is hypothesized that participants randomly assigned to the higher protein dietary treatment will lose more weight based on BMI-Z score over 12 weeks compared to participants in the lower dietary protein treatment.

Aim 2 is to test if changes in subjective ratings of appetite differ by dietary treatment (i.e. protein intake).

It is hypothesized that participants in the higher protein intervention will report a decrease in hunger and an increase in fullness compared to participants in the lower protein intervention.

Aim 3 is to test if change in the hexosamine biosynthetic pathway (HBP) measured at the rate limiting step of glutamine fructose-6-phosphate amidotransferase (GFAT) and glycosylation measured as O-linked N-acetylglucosamine (GlcNAc) transferase (OGT) differ by dietary treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
12 Years 至 17 Years(Child)
性别
All
接受健康志愿者
是

入选标准

  • •Be male or female
  • •Be between the ages of 12 and 17, inclusive
  • •Be at or above the 85th BMI percentile (a number calculated from the participants height, weight, sex, and date of birth)
  • •Be willing to fast for 12 hours prior to clinic study visits 2 and 4
  • •Be willing to participate in the research study

排除标准

  • •Health Conditions:
  • •Has HIV or AIDS
  • •Has uncontrolled CVD or arrhythmia
  • •Has Type I or Type II diabetes.
  • •Is unable or unwilling to complete the study procedures
  • •Participant may not qualify for this study based on other exclusion criteria not listed. The study coordinator will go over this information in detail.
  • •Medications:
  • •Diuretics
  • •Beta-blocker
  • •Weight loss medications, diet pills
  • •Anti-inflammatory drugs (corticosteroid/anabolic steroid/NSAID)
  • •Antipsychotic medications
  • •Other medications that may affect fluid balance or weight
  • •Plans to move out of the study area within the next 4 months, or plan to be out of the study area for more than 3 weeks during the course of the study.

研究组 & 干预措施

Higher protein and energy restriction

Experimental

Participants in this arm will consume 30% of energy as protein with 25% energy restriction.

干预措施: Energy Restriction (Behavioral)

Higher protein and energy restriction

Experimental

Participants in this arm will consume 30% of energy as protein with 25% energy restriction.

干预措施: Higher protein (Behavioral)

Lower protein and energy restriction

Experimental

Participants in this arm will consume 15% of energy as protein with 25% energy restriction.

干预措施: Energy Restriction (Behavioral)

Lower protein and energy restriction

Experimental

Participants in this arm will consume 15% of energy as protein with 25% energy restriction.

干预措施: Lower Protein (Behavioral)

结局指标

主要结局

BMI Z-Score

时间窗: up to Week 12

次要结局

  • Subjective Ratings of Appetite(Baseline and Week 12)
  • Hexosamine Biosynthetic Pathway(Baseline and Week 12)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

John Apolzan

Assistant Professor

Pennington Biomedical Research Center

研究点 (1)

Loading locations...

相似试验